cellsciencesystems.com Listed by safepay Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups continue to pressure organizations by listing alleged victims on leak sites, a tactic that has become a regular feature of the threat landscape in 2024 and 2025. Healthcare and clinical laboratory providers remain frequent targets because of the sensitive personal and medical data they handle and the operational disruption that can follow an attack. Against that backdrop, cellsciencesystems.com appeared on a listing attributed to the safepay ransomware group on January 25, 2025.

Public detail about the incident remains limited. What is known is that the group claims to have exfiltrated internal files in a ransomware attack against the organization. The number of people affected has not been disclosed, and no independent confirmation of the full scope has been made public. For patients, providers, and partners who may have interacted with Cell Science Systems, the listing raises clear questions about what information could be at risk and what practical steps to take next.

Breaking down the breach

According to available reporting, cellsciencesystems.com was listed by the safepay ransomware group on January 25, 2025. The group claims that internal files were exfiltrated as part of a ransomware attack. No further technical details—such as the initial access method, the precise date of intrusion, the volume of data taken, or whether systems were encrypted—have been publicly confirmed. The number of individuals potentially affected is listed as unknown. In short, the core public fact is the leak-site claim itself; everything else about timing, scale, and method remains undisclosed at this stage.

Ransomware incidents of this type typically involve both encryption of systems and theft of data for leverage. Because the listing is presented by the threat actor, it should be treated as an unverified claim until the organization or independent investigators provide corroboration. No dollar amounts, file counts, or specific system names have been released in connection with this report.

Who is safepay?

Safepay is a ransomware operation that has been observed publicly since roughly mid-2024. Like many contemporary groups, it is associated with double-extortion tactics: encrypting victim systems while also stealing data and threatening to publish it on a dedicated leak site if a ransom is not paid. The group has listed organizations across multiple sectors, using the familiar pattern of posting victim names, sometimes with sample files or countdown timers, to increase pressure.

Public reporting on safepay describes relatively standard ransomware tooling and affiliate-style operations rather than highly distinctive custom malware. The group’s leak-site listings are claims made by the actors themselves; they do not automatically prove that every listed organization suffered a claimed breach of the scale or content the group asserts. In this case, the only specific assertion tied to cellsciencesystems.com is that internal files were exfiltrated. No additional statements attributed to safepay about this particular victim appear in the available facts.

Who is cellsciencesystems.com?

Cell Science Systems is a specialty clinical laboratory focused on immunology and cell biology testing. It develops and performs laboratory assays intended to help healthcare providers diagnose, treat, and monitor complex disorders. The organization is known for pioneering the Alcat Test, which assesses food and chemical sensitivities. Results from such testing are used to support personalized treatment plans for conditions that can include digestive issues, migraines, obesity, chronic fatigue, joint pain, and skin disorders.

As a clinical laboratory, the company sits at the intersection of healthcare delivery and diagnostic data. Organizations of this type typically maintain patient identifiers, test orders and results, referring-provider information, billing records, and internal operational documents. A ransomware incident affecting such an entity is consequential because it can interrupt laboratory operations, delay results that clinicians rely on, and place sensitive health-related information at risk of exposure or misuse. The facts do not state that any particular category of patient data was confirmed stolen; they only record the claim of internal-file exfiltration.

What was likely exposed

The only data type named in connection with the incident is “internal files exfiltrated in ransomware attack.” No inventory of specific file categories, patient records, employee data, or financial documents has been publicly disclosed. Because the exact contents remain unconfirmed, it is not possible to state as fact what was taken.

Organizations operating specialty clinical laboratories commonly hold patient demographic information, laboratory test results (including sensitivity and immunology panels), physician referral data, insurance or billing details, and internal research or quality-control documents. They may also store employee records and vendor contracts. Any or none of these categories could be among the internal files the group claims to have removed; public reporting simply does not confirm the contents. Readers should treat the exposure as a possibility rather than a verified list of data elements.

The real-world impact

For individuals whose information may have been held by Cell Science Systems, the primary risks are those associated with any healthcare-related data exposure: potential misuse of personal identifiers, targeted phishing that references medical testing, or attempts at medical identity fraud. Even when clinical results themselves are not published, the knowledge that a person sought specialized sensitivity or immunology testing can be sensitive. Because the number of people affected is unknown and the precise data types are unconfirmed, the scale of individual harm cannot be quantified from public sources.

For the organization, a ransomware incident can mean temporary disruption of laboratory operations, costs associated with investigation and recovery, and the need to notify regulators and affected parties if protected health information is determined to have been involved. Reputational and contractual consequences with referring clinicians and patients are also possible. None of these outcomes are established as having already occurred; they represent the ordinary range of consequences that follow such claims in the clinical-laboratory sector.

If your data was in this claimed breach

If you have been a patient, employee, or partner of Cell Science Systems, treat the listing as a reason for heightened caution rather than confirmed personal exposure. Monitor financial and medical statements for unexpected activity, be alert to phishing messages that reference laboratory testing or food-sensitivity results, and consider placing fraud alerts with credit bureaus if you believe your identifiers may have been involved. Change passwords on any accounts that reused credentials associated with the organization, and enable multi-factor authentication where available.

Because public detail is limited, the most practical next step for many people is simply to check whether their email address has already appeared in known breach datasets. Free exposure-scan tools can surface that information without requiring payment or the disclosure of additional personal data. If new official notifications are issued by the company or by regulators, follow the specific guidance they provide. Until then, measured vigilance and basic account hygiene remain the most useful responses.

AICompiled with AI assistance from public sources and published under our editorial standards.